G01N 2800/708
Nitrogen metabolism
Official title: Nitrogen metabolism, e.g. urea cycle
G01N2800/708 (Nitrogen metabolism) appears on 4 US grants and 16 published applications in this corpus.
Search patents in G01N- Granted patents
- 4
- Published applications
- 16
- Assignees
- 7
- Inventors
- 13
- Latest grant
- 2 Jun 2020
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2014 | 0 | 1 |
| 2015 | 0 | 1 |
| 2016 | 1 | 1 |
| 2017 | 1 | 6 |
| 2018 | 0 | 2 |
| 2019 | 1 | 1 |
| 2020 | 1 | 2 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
| 2025 | 0 | 1 |
By publication year.
Recent patents
- Treatment of urea cycle disorders in neonates and infants2 Jun 2020US 10,668,040 B2Horizon Therapeutics, LLC
- Mouse model of hyperuricemia11 Jun 2019US 10,314,295 B2Phoenixbio Co., Ltd.
- Compositions, apparatus and methods for monitoring biomarkers12 Sep 2017US 9,759,716 B2Berkeley NOX Limited
- Compositions, apparatus and methods for monitoring biomarkers7 Jun 2016US 9,360,490 B2Berkeley Test, LLC
- Reexpression of hnf4a to alleviate cancer-associated cachexia20 Feb 2025US 2025/0057985 A1Technion Research & Development Foundation Limited
- Method for assessing mitochondrial function in tissue or organ other than kidney in test subject22 Feb 2024US 2024/0060996 A1Hamamatsu Photonics K.K.
- Methods of treating urea cycle disorders31 Dec 2020US 2020/0405678 A1Horizon Therapeutics, LLC
- Treatment of urea cycle disorders in neonates and infants17 Dec 2020US 2020/0390735 A1Horizon Therapeutics, LLC
- Treatment of urea cycle disorders in neonates and infants14 Mar 2019US 2019/0076386 A1Horizon Therapeutics, LLC
Most cited
By later US patents